Andrew Booth - 10 Dec 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Financial Officer
Signature
/s/ Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
10 Dec 2021
Transactions value $
$160,000
Form type
4
Filing time
10 Dec 2021, 16:00:14 UTC
Previous filing
09 Dec 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Options Exercise $160K +500K +934.58% $0.32* 554K 10 Dec 2021 Direct
holding ABCL Common Shares 131K 10 Dec 2021 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share Options (right to buy) Options Exercise $0 -500K -8.5% $0.00 5.38M 10 Dec 2021 Common Shares 500K $0.32 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.